PreciseDx: UCLA, PreciseDx to Develop AI-Powered Breast Cancer Recurrence Tool for Early Detection

What You Should Know: - PreciseDx®, a leader in AI-powered diagnostics for oncology, announces a crucial collaboration with UCLA's Department of Pathology and Laboratory Medicine. - The research initiative focuses on evaluating PreciseDx's innovative tool, PreciseBreast , for its ability to accurately assess the risk of recurrence in patients diagnosed with triple-negative breast cancer (TNBC). Why ... Read More